Relief Therapeutics 组建执行委员会。 Relief Therapeutics forms executive committee.

罕见疾病生物制药公司 Relief Therapeutics 宣布成立新的执行委员会，并任命首席财务官、首席人力资源官以及法律和合规主管，以加强其团队。 Relief Therapeutics, a rare disease biopharmaceutical company, announced the formation of a new executive committee, strengthening its team with appointments of a CFO, CHRO, and Head of Legal and Compliance. Andrew Einhorn 加入公司担任首席财务官，并拥有在临床和商业阶段生命科学公司担任高级领导职务的丰富经验。 Andrew Einhorn joins as CFO, bringing extensive experience from senior leadership roles in clinical and commercial-stage life science companies. 此次扩张旨在指导公司完成管道开发计划。 This expansion aims to guide the company through pipeline development initiatives.